哈药股份
(600664)
| 流通市值：97.21亿 | | | 总市值：97.21亿 |
| 流通股本：25.19亿 | | | 总股本：25.19亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 12,256,440,508.95 | 8,142,196,595.69 | 4,142,160,958.07 | 15,456,578,104.4 |
| 营业收入 | 12,256,440,508.95 | 8,142,196,595.69 | 4,142,160,958.07 | 15,456,578,104.4 |
| 二、营业总成本 | 11,561,514,820.89 | 7,680,821,719.47 | 3,915,903,736.03 | 14,807,716,017.62 |
| 营业成本 | 8,796,789,715.71 | 5,761,596,791.69 | 2,965,588,314.24 | 11,404,770,476 |
| 税金及附加 | 96,253,591.76 | 64,120,979.56 | 31,736,571.38 | 118,187,139.07 |
| 销售费用 | 1,965,792,933.38 | 1,387,957,739.1 | 682,482,283.54 | 2,311,530,650.56 |
| 管理费用 | 595,629,906.67 | 400,383,461.15 | 207,602,537.7 | 839,497,248.57 |
| 研发费用 | 81,093,964.69 | 53,412,127.05 | 25,265,801 | 106,015,499.23 |
| 财务费用 | 25,954,708.68 | 13,350,620.92 | 3,228,228.17 | 27,715,004.19 |
| 其中:利息费用 | 41,796,080.06 | 27,114,570.26 | 13,723,548.89 | 56,468,349.57 |
| 其中:利息收入 | 26,518,277.53 | 20,353,748.33 | -13,511,422.76 | 47,096,752.5 |
| 加:公允价值变动收益 | 0 | - | - | - |
| 加:投资收益 | 12,786,380.38 | 12,786,380.38 | - | 4,483,228.47 |
| 净敞口套期收益 | 0 | - | - | - |
| 汇兑收益 | 0 | - | - | - |
| 资产处置收益 | 887,473.94 | 212,567.76 | 143,777.25 | 1,333,760.51 |
| 资产减值损失(新) | -12,045,848.65 | -8,064,412.87 | 1,941,627.18 | -45,066,567.23 |
| 信用减值损失(新) | -22,751,656.34 | -26,090,014.72 | -4,202,170.31 | -33,657,291.52 |
| 其他收益 | 47,823,011.54 | 35,812,690.09 | 20,991,522.66 | 83,674,232.8 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 721,625,048.93 | 476,032,086.86 | 245,131,978.82 | 659,629,449.81 |
| 加:营业外收入 | 3,827,160.4 | 3,085,607.86 | 312,376.33 | 2,426,643.39 |
| 减:营业外支出 | 14,759,496.41 | 9,591,450.49 | 364,674.56 | 11,516,270.05 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 710,692,712.92 | 469,526,244.23 | 245,079,680.59 | 650,539,823.15 |
| 减:所得税费用 | 162,944,528.15 | 106,370,646.92 | 54,772,854.67 | 176,321,650.26 |
| 六、净利润 | 547,748,184.77 | 363,155,597.31 | 190,306,825.92 | 474,218,172.89 |
| 持续经营净利润 | 547,748,184.77 | 363,155,597.31 | 190,306,825.92 | 474,218,172.89 |
| 归属于母公司股东的净利润 | 508,286,408.86 | 343,386,381.89 | 176,741,385.26 | 395,263,436.89 |
| 少数股东损益 | 39,461,775.91 | 19,769,215.42 | 13,565,440.66 | 78,954,736 |
| (一)基本每股收益 | 0.2 | 0.14 | 0.07 | 0.16 |
| (二)稀释每股收益 | 0.2 | 0.14 | 0.07 | 0.16 |
| 八、其他综合收益 | 399,007.61 | -425,839.67 | 6,524.94 | 31,430.14 |
| 归属于母公司股东的其他综合收益 | 399,007.61 | -425,839.67 | 6,524.94 | 31,430.14 |
| 九、综合收益总额 | 548,147,192.38 | 362,729,757.64 | 190,313,350.86 | 474,249,603.03 |
| 归属于母公司股东的综合收益总额 | 508,685,416.47 | 342,960,542.22 | 176,747,910.2 | 395,294,867.03 |
| 归属于少数股东的综合收益总额 | 39,461,775.91 | 19,769,215.42 | 13,565,440.66 | 78,954,736 |
| 公告日期 | 2024-10-26 | 2024-08-23 | 2024-04-26 | 2024-04-11 |
| 审计意见(境内) | | | | 标准无保留意见 |